PharmaShots | Incisive News in 3 Shots

Subscribe Now

mOS

The NMPA Approves Innovent Biologics’ Dupert (Fulzerasib) to Treat NSCLC

The NMPA Approves Innovent Biologics’ Dupert (Fulzerasib) to Treat NSCLC

August 22, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us